Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

3/1/2013 (1 year ago)

Catholic Online (www.catholic.org)

Pancreatitis is rare but more common in people with type 2 diabetes

Those who take a form of medication to control their diabetes may be at increased risk of developing an inflamed pancreas, according to a new study. Glucagonlike peptide 1(GLP-1) therapies that include exenatide and sitagliptin, which is marketed as Januvia by Merck have been linked to pancreatitis before in studies on animals and small groups of patients.

The U.S. Centers for Disease Control and Prevention estimates that there are about 19 million Americans diagnosed with diabetes, and another 7 million who have the disease but don't know it -- yet.

The U.S. Centers for Disease Control and Prevention estimates that there are about 19 million Americans diagnosed with diabetes, and another 7 million who have the disease but don't know it -- yet.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

3/1/2013 (1 year ago)

Published in Health

Keywords: Diabetes, pancreatitis, medication, practice


LOS ANGELES, CA (Catholic Online) - "New therapies and risks are only evaluated when studies are done. We need to know (the drugs) are effective in lowering blood sugar, but we also need to know about risks," Dr. Sonal Singh, from the Johns Hopkins University School of Medicine in Baltimore says.

Pancreatitis is a rare but common condition among those on diabetic medication. It is more common in people with type 2 diabetes. Singh said pancreatitis occurs in about three of every 1,000 diabetes patients.

The U.S. Centers for Disease Control and Prevention estimates that there are about 19 million Americans diagnosed with diabetes, and another 7 million who have the disease but don't know it -- yet.

In type 2 diabetes, the body doesn't produce enough insulin or is resistant to what it does produce.

Researchers used data on 1,269 diabetes patients between the ages of 18 and 64 years old, who were admitted to U.S. hospitals with pancreatitis in 2005 through 2008. They compared those to 1,269 other diabetes patients who were similar, but were not hospitalized with pancreatitis.

Researchers found that 87 of the diabetes patients with pancreatitis were taking GLP-1 therapies, compared to 58 of the diabetes patients without pancreatitis.

Singh told Reuters Health that the findings show the drugs are linked to a doubling of the risk of pancreatitis, which is about six cases per 1,000 diabetics.

"I won't say you should be alarmed about the findings, but it's something you should consider," he said.

Staff endocrinologist in the clinic of the Joslin Diabetes Center in Boston, Dr. Aaron Cypess, said the new study will not change how he treats patients, but it may influence him to go over his patients' risk factors for pancreatitis.

"For me personally it's not going to change my practice pattern in terms of stopping the drugs, but we may revisit whether you're showing any of the risk factors," Cypess said.

In a joint statement, the American Diabetes Association and the American Association of Clinical Endocrinologists also said the new findings should not change how doctors treat diabetes patients.

"The analysis is a retrospective study using data from an administrative database. This type of analysis is not considered as robust as a prospective randomized controlled clinical trial, the gold standard for evaluating treatments," the organizations wrote in the statement.

---


Pope Francis: end world hunger through 'Prayer and Action'


2014 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for August 2014
Refugees:
That refugees, forced by violence to abandon their homes, may find a generous welcome and the protection of their rights.
Oceania: That Christians in Oceania may joyfully announce the faith to all the people of that region.



Comments


More Health

NEW HOPE IN EBOLA CRISIS: U.S. doctor released from hospital - cured Watch

Image of

By Catholic Online (NEWS CONSORTIUM)

Contracting the deadly African virus while he worked to save their lives, Dr. Kent Brantly became one of the handful of people from the United States to contract Ebola. Receiving treatment back in the U.S., Brantly walked out of the hospital to the waiting arms ... continue reading


HEALTH DISASTER: Is nearly half of all Americans destined to contract diabetes? Watch

Image of The irony of the situation is that Americans are generally living longer, which is a factor in their increased lifetime chance of developing type 2 diabetes. Americans are also not dying in the same proportions that they were, because of better treatment.

By Catholic Online (NEWS CONSORTIUM)

Has the United States reached the tipping point with diabetes and obesity? A shocking new study claims that nearly HALF of all Americans, if trends continue, will develop type 2 diabetes in the near future. Public Health England, in their most recent report ... continue reading


First large-scale shipment of new malaria drug shipped out Watch

Image of The recent shipment marks a new phase in the fight against the mosquito-borne disease.

By Catholic Online (NEWS CONSORTIUM)

Just as virulent - as far more easily transmitted than Ebola, malaria is making new inroads to populations in sub-Saharan Africa. In response, French drug maker Sanofi has announced the delivery of large-scale batches of an antimalarial drug made using ... continue reading


Very accurate colon cancer in-home detection kit approved by FDA Watch

Image of  The U.S. Food and Drug Administration has approved a new at-home, DNA-based stool test that screens for colorectal cancer with more than 90 percent accuracy.

By Catholic Online (NEWS CONSORTIUM)

Screening for colon cancer is frequently arduous and invasive. Patients need to fast prior to a colonoscopy, and the colonoscopy itself be highly uncomfortable and not always accurate. There's now good news for those at risk. The U.S. Food and Drug ... continue reading


You'll think twice before you put this dangerous chemical back in your mouth! Watch

Image of Colgate's Total brand of toothpaste contains the chemical triclosan, which has been proven to cause disruptions in the endocrine system in mice and rats.

By Catholic Online (NEWS CONSORTIUM)

A top-selling toothpaste uses the chemical triclosan which has been linked to cancer-cell growth and disrupted development in animals, and regulators are still reviewing whether or not it's safe to pt in soap, cutting boars and toys, while many consumer companies ... continue reading


New diabetes drug could help us all: Found effective in preventing cancer Watch

Image of Scientists who studied more than 180,000 people found a

By Catholic Online (NEWS CONSORTIUM)

According to a new study, a drug widely prescribed to treat type 2 diabetes could help us all live longer. Said drug, metformin, which controls glucose levels, may also stave off cardiovascular disease and cancer, regardless if the person is diabetic. LOS ... continue reading


Mutated gene increases women's chance for breast cancer by threefold Watch

Image of Doctors also could recommend more aggressive surveillance for breast cancer, such as annual mammograms or MRI breast screening.

By Catholic Online (NEWS CONSORTIUM)

A new study has found that mutated versions of a gene called PALB2 can dramatically increase a woman's risk of breast cancer. Researchers say that women carrying the PALB2 mutation have a one in three chance of developing breast cancer by the age of 70. LOS ... continue reading


WAS WORLD'S THROAT CUT? Ebola vaccine research was earlier abandoned Watch

Image of It must also be noted that while the National Institutes of Health and the U.S. government often fund the early animal safety and efficacy testing of a vaccine, pharmaceutical companies typically fund the human clinical trials to take a drug or vaccine to market.

By Catholic Online (NEWS CONSORTIUM)

With increasing fears of the Ebola virus in West Africa and elsewhere, world governments are now frantically trying to contain the disease. What is not widely known is the fact that there had been work on finding a vaccine for Ebola four years ago, that was ... continue reading


PLAGUE STRIKES HOME: At least six people tested for Ebola in U.S. Watch

Image of Said individual, who has recently traveled to West Africa where the current outbreak is taking place is said to be under

By Catholic Online (NEWS CONSORTIUM)

At least six people within the continental United States have been tested for the dreaded Ebola virus, the deadly hemorrhagic disease tearing through West Africa. While all six people tested negative, the states in which these people were from remains a tightly ... continue reading


NEW THERAPY: Will chemotherapy be rendered obsolete in 20 years' time? Watch

Image of Genome sequencing will help drug companies design medicines that can successfully target the tumor, according to Professor Jeremy Farrar, director of the Wellcome Trust, which is part of the project.

By Catholic Online (NEWS CONSORTIUM)

Chemotherapy is regime that many cancer patients undergo. Many feel that the cure is at times worse than the disease: Weeks of nausea, fatigue, pain and disorientation. Now, drugs that target cancer without harming healthy cells that trigger harmful side ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Ezekiel 43:1-7
1 He took me to the gate, the one facing ... Read More

Psalm, Psalms 85:9-10, 11-12, 13-14
9 His saving help is near for those who fear him, his ... Read More

Gospel, Matthew 23:1-12
1 Then addressing the crowds and his disciples Jesus ... Read More

Saint of the Day

Saint of the Day for August 23rd, 2014 Image

St. Philip Benizi
August 23: Servite cardinal and preacher. Born in Florence, Italy, to a ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter